证券记录 · 已归档季度
TFX
Teleflex Incorporated · Healthcare · Medical - Instruments & Supplies
16被追踪持有人
—Δ持有人
4.92M持有股份
$1.03B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 114 | +2 | 26.38M | $3.34B | +8 | −5 |
| Q1 2026 | 114 | +1 | 27.79M | $3.32B | +11 | −11 |
| Q4 2025 | 113 | -1 | 32.06M | $3.91B | +1 | −1 |
| Q3 2025 | 18 | -1 | 20.02M | $2.45B | — | −2 |
| Q2 2025 | 17 | +1 | 15.00M | $1.78B | +1 | — |
| Q1 2025 | 13 | -2 | 4.93M | $680.71M | +1 | −3 |
| Q4 2024 | 15 | -1 | 5.33M | $947.44M | +1 | −2 |
| Q3 2024 | 15 | -1 | 3.86M | $954.17M | +1 | −2 |
| Q2 2024 | 16 | — | 4.92M | $1.03B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 1.30M | — | $272.48M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 1.30M | — | $272.48M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 1.30M | — | $272.48M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 1.30M | — | $272.48M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.30M | — | $272.48M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.30M | — | $272.48M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.30M | — | $272.48M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 1.12M | — | $235.97M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (被动) | 1.12M | — | $235.97M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.03M | — | $215.70M | 0.2% | n/c | 1 | SEC ↗ |
| 11 | Norges Bank ✦ (被动) | 548.87K | — | $115.44M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 310.48K | — | $65.30M | 0.2% | n/c | 1 | SEC ↗ |
| 13 | Glenview Capital ✦ | 122.48K | — | $25.76M | 0.5% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 108.14K | — | $22.75M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 108.14K | — | $22.75M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Adage Capital Partners ✦ | 95.20K | — | $20.02M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 93.71K | — | $19.71M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 93.71K | — | $19.71M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 59.71K | — | $12.36M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 59.71K | — | $12.36M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 42.12K | — | $8.86M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 41.80K | — | $8.79M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 30.36K | — | $6.38M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 12.63K | — | $2.66M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 9.60K | — | $2.02M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Fisher Asset Management ✦ | 2.70K | — | $567,465 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 364 持有人, 47.78M 股份, $5.00B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据